Monday, January 23, 2017

“Breathometer” Marketers Settle FTC Charges

Remember that “Breathometer” cell phone attachment that could supposedly measure your blood alcohol content level? Apparently there was no scientific evidence proving that it actually worked. Whoops!
The marketers of two app-supported smartphone accessories, marketed to accurately measure consumers’ blood alcohol content (BAC), have agreed to settle Federal Trade Commission charges that they lacked scientific evidence to back up their advertising claims. Under the terms of the FTC settlement, defendants Breathometer, Inc., and the company’s founder and chief executive officer Charles Michael Yim, are barred from making future accuracy claims for a consumer breathalyzer product unless such claims are supported by rigorous testing. The defendants also are required to notify and pay full refunds to consumers who bought their devices.